Related references
Note: Only part of the references are listed.Spiro[4,4]-1,6-nonadiene-Based Phosphine-Oxazoline Ligands for Iridium-Catalyzed Enantioselective Hydrogenation of Ketimines
Zhaobin Han et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Recent advances in glucokinase activators for the treatment of type 2 diabetes
Manojit Pal
DRUG DISCOVERY TODAY (2009)
Structural requirements for substrate in highly enantioselective hydrogenation over the cinchonidine-modified Pd/C
Takashi Sugimura et al.
JOURNAL OF CATALYSIS (2009)
Glucokinase Activators for the Potential Treatment of Type 2 Diabetes
J. Grimsby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Glucokinase activators in diabetes management
Matthew Coghlan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides:: Discovery of PSN-GK1
Lisa S. Bertram et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Bis-(2,5-diphenylphospholanes) with sp2 carbon linkers:: Synthesis and application in asymmetric hydrogenation
Martin E. Fox et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Iridium-catalyzed enantioselective hydrogenation of α,β-unsaturated carboxylic acids
Shen Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Iridium-catalyzed asymmetric hydrogenation of olefins
Stephen J. Roseblade et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions
M. C. T. Fyfe et al.
DIABETOLOGIA (2007)
Stereoselective synthesis of ferrocene-based C2-symmetric diphosphine ligands:: Application to the highly enantioselective hydrogenation of α-substituted cinnamic acids
Weiping Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Rh-catalyzed highly enantioselective synthesis of 3-arylbutanoic acids
Xianfeng Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
The asymmetric hydrogenation of 2-phenethylacrylic acid as key step for the enantioselective synthesis of Citralis Nitrile®
Alberto Scrivanti et al.
TETRAHEDRON LETTERS (2006)
Asymmetric hydrogenation of α,β-unsaturated carboxylic acids catalyzed by ruthenium(II) complexes of spirobifluorene diphosphine (SFDP) ligands
Xu Cheng et al.
ADVANCED SYNTHESIS & CATALYSIS (2006)
A new class of versatile chiral-bridged atropisomeric diphosphine ligands: Remarkably efficient ligand syntheses and their applications in highly enantioselective hydrogenation reactions
LQ Qiu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Small molecule glucokinase activators as glucose lowering agents: A new paradigm for diabetes therapy
Kevin R. Guertin et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Current technologies for the production of (S)-ketoprofen:: Process perspective
AL Ong et al.
PROCESS BIOCHEMISTRY (2005)
Chiral (Iminophosphoranyl)ferrocenes: A new class of practical ligands for rhodium-catalyzed asymmetric hydrogenation
TT Co et al.
ORGANOMETALLICS (2005)
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors
M Allegretti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis of PPAR agonist via asymmetric hydrogenation of a cinnamic acid derivative and stereospecific displacement of (S)-2-chloropropionic acid
IN Houpis et al.
ORGANIC LETTERS (2005)
Achiral ligands dramatically enhance rate and enantioselectivity in the Rh/phosphoramidite-catalyzed hydrogenation of alpha,beta-disubstituted unsaturated acids
R Hoen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Highly rigid diphosphane ligands with a large dihedral angle based on a chiral spirobifluorene backbone
X Cheng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Enantioselective hydrogenation of α-aryloxy α,β-unsaturated acids.: Asymmetric synthesis of α-aryloxycarboxylic acids
PE Maligres et al.
ORGANIC LETTERS (2004)
New chiral phosphorus ligands for enantioselective hydrogenation
WJ Tang et al.
CHEMICAL REVIEWS (2003)
Allosteric activators of glucokinase: Potential role in diabetes therapy
J Grimsby et al.
SCIENCE (2003)
[2′,6′-dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group:: Potent and selective κ opioid antagonists
YX Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Highly effective chiral dipyridylphosphine ligands: Synthesis, structural determination, and applications in the Ru-catalyzed asymmetric hydrogenation reactions
CC Pai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
